FDA puts full clinical hold on CTI BioPharma's blood cancer drug

February 10, 2016 2:44 AM

2 0

FDA puts full clinical hold on CTI BioPharma's blood cancer drug

CTI BioPharma Corp said the U.S Food and Drug Administration has put a full clinical hold on the company's investigational new drug application for pacritinib.

CTI said it has withdrawn its application for the experimental blood cancer drug and will now review the safety and efficacy data.

Also read: Senate Clears Bill to Ease FDA Drug and Device Approvals

Read more

To category page

Loading...